Home > Compound List > Product Information
Bortezomib_Molecular_structure_CAS_179324-69-7)
Click picture or here to close

Bortezomib

Catalog No. B675700 Name Toronto Research Chemicals
CAS Number 179324-69-7 Website http://www.trc-canada.com
M. F. C19H25BN4O4 Telephone +1 (416) 665-9696
M. W. 384.2372 Fax +1 (416) 665-4439
Purity Email info@trc-canada.com
Storage Hygroscopic, -20°C Freezer, Under Inert Atmosphere Chembase ID: 5119

SYNONYMS

IUPAC name
[(1R)-3-methyl-1-[(2S)-3-phenyl-2-(pyrazin-2-ylformamido)propanamido]butyl]boronic acid
IUPAC Traditional name
bortezomib
Synonyms
MG 341
PS 341
B-[(1R)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic Acid
Velcade
[(1R)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic Acid
MLN 341
Radiciol
NSC 681239
DPBA
LDP 341
PS 314

DATABASE IDS

CAS Number 179324-69-7

PROPERTIES

Certificate of Analysis Download
Apperance White to Off-White Solid
Melting Point 122-124°C
Solubility Chloroform
Solubility Dimethyl Sulfoxide
Solubility Ethanol
Solubility Methanol
MSDS Link Download
Storage Condition Hygroscopic, -20°C Freezer, Under Inert Atmosphere

DETAILS

Description (English)
Bortezomib is the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells.

REFERENCES

  • Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005)
  • Drahl C.: Chem. and Eng. News, 87, 41 (2009)